한국어
English
日本語
中文(简体)Agripal S1 Pre-filled Syringe (Influenza Surface Antigen Vaccine)
15μg
Prescription medication · Combination
Seqirus Korea Co., Ltd.
Inactivated Influenza Virus Antigen Type A is a vaccine component for the prevention of Influenza A virus infection.
MFDS ingredient code M264137
This component is a vaccine ingredient that purifies and inactivates the surface antigens of the Influenza A virus. It is primarily used to prevent influenza infection and helps the immune system recognize and respond to the virus.
Once this component enters the body, the immune system recognizes the virus antigens and produces antibodies. These formed antibodies act quickly to respond and prevent infection when the actual influenza virus invades.
Approved uses differ by product. Check each product's information for its actual use.
This component contains only inactivated antigens, not live viruses, which enhances safety. Unlike other vaccine components, it is specifically formulated to target certain strains of the Influenza A virus, eliciting an effective immune response.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.